AIMC Topic: Late Onset Disorders

Clear Filters Showing 1 to 3 of 3 articles

Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.

PloS one
We evaluated the utility of leucocyte epigenomic-biomarkers for Alzheimer's Disease (AD) detection and elucidates its molecular pathogeneses. Genome-wide DNA methylation analysis was performed using the Infinium MethylationEPIC BeadChip array in 24 l...

A Machine Learning Approach to Identifying Placebo Responders in Late-Life Depression Trials.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
OBJECTIVE: Despite efforts to identify characteristics associated with medication-placebo differences in antidepressant trials, few consistent findings have emerged to guide participant selection in drug development settings and differential therapeu...